These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 12690223

  • 21. Synergistic effect of an endothelin type A receptor antagonist, S-0139, with rtPA on the neuroprotection after embolic stroke.
    Zhang RL, Zhang C, Zhang L, Roberts C, Lu M, Kapke A, Cui Y, Ninomiya M, Nagafuji T, Albala B, Zhang ZG, Chopp M.
    Stroke; 2008 Oct; 39(10):2830-6. PubMed ID: 18669895
    [Abstract] [Full Text] [Related]

  • 22. Comparative effects of tissue plasminogen activator, streptokinase, and staphylokinase on cerebral ischemic infarction and pulmonary clot lysis in hamster models.
    Nagai N, Vanlinthout I, Collen D.
    Circulation; 2008 Oct; 100(25):2541-6. PubMed ID: 10604893
    [Abstract] [Full Text] [Related]

  • 23. A combined treatment with tacrolimus (FK506) and recombinant tissue plasminogen activator for thrombotic focal cerebral ischemia in rats: increased neuroprotective efficacy and extended therapeutic time window.
    Maeda M, Furuichi Y, Ueyama N, Moriguchi A, Satoh N, Matsuoka N, Goto T, Yanagihara T.
    J Cereb Blood Flow Metab; 2002 Oct; 22(10):1205-11. PubMed ID: 12368659
    [Abstract] [Full Text] [Related]

  • 24. Adjuvant therapies using normobaric oxygen with hypothermia or ethanol for reducing hyperglycolysis in thromboembolic cerebral ischemia.
    Cai L, Stevenson J, Peng C, Xin R, Rastogi R, Liu K, Geng X, Gao Z, Ji X, Rafols JA, Ji Z, Ding Y.
    Neuroscience; 2016 Mar 24; 318():45-57. PubMed ID: 26794589
    [Abstract] [Full Text] [Related]

  • 25. New thrombolytic strategy providing neuroprotection in experimental ischemic stroke: MMP10 alone or in combination with tissue-type plasminogen activator.
    Roncal C, Martinez de Lizarrondo S, Salicio A, Chevilley A, Rodriguez JA, Rosell A, Couraud PO, Weksler B, Montaner J, Vivien D, Páramo JA, Orbe J.
    Cardiovasc Res; 2017 Aug 01; 113(10):1219-1229. PubMed ID: 28379489
    [Abstract] [Full Text] [Related]

  • 26. Very Mild Hypothermia (35°C) Postischemia Reduces Infarct Volume and Blood/Brain Barrier Breakdown Following tPA Treatment in the Mouse.
    Cechmanek BK, Tuor UI, Rushforth D, Barber PA.
    Ther Hypothermia Temp Manag; 2015 Dec 01; 5(4):203-8. PubMed ID: 26075540
    [Abstract] [Full Text] [Related]

  • 27. Intravenous infusion of mesenchymal stem cells inhibits intracranial hemorrhage after recombinant tissue plasminogen activator therapy for transient middle cerebral artery occlusion in rats.
    Nakazaki M, Sasaki M, Kataoka-Sasaki Y, Oka S, Namioka T, Namioka A, Onodera R, Suzuki J, Sasaki Y, Nagahama H, Mikami T, Wanibuchi M, Kocsis JD, Honmou O.
    J Neurosurg; 2017 Oct 01; 127(4):917-926. PubMed ID: 28059661
    [Abstract] [Full Text] [Related]

  • 28. Therapeutic effect of tPA in ischemic stroke is enhanced by its combination with normobaric oxygen and hypothermia or ethanol.
    Ji Z, Liu K, Cai L, Peng C, Xin R, Gao Z, Zhao E, Rastogi R, Han W, Rafols JA, Geng X, Ding Y.
    Brain Res; 2015 Nov 19; 1627():31-40. PubMed ID: 26319679
    [Abstract] [Full Text] [Related]

  • 29. Thrombolysis with rt-PA under Rivaroxaban Anticoagulation in a Hypertensive Rat Model of Intraluminal Middle Cerebral Artery Occlusion.
    Izuma H, Oka F, Ishihara H, Inoue T, Suehiro E, Nomura S, Suzuki M.
    J Stroke Cerebrovasc Dis; 2018 Oct 19; 27(10):2761-2767. PubMed ID: 30056000
    [Abstract] [Full Text] [Related]

  • 30. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
    Ratilal BO, Arroja MM, Rocha JP, Fernandes AM, Barateiro AP, Brites DM, Pinto RM, Sepodes BM, Mota-Filipe HD.
    J Neurosurg; 2014 Jul 19; 121(1):55-62. PubMed ID: 24702327
    [Abstract] [Full Text] [Related]

  • 31. Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke.
    Zhang L, Zhang ZG, Zhang RL, Lu M, Krams M, Chopp M.
    Stroke; 2003 Jul 19; 34(7):1790-5. PubMed ID: 12805500
    [Abstract] [Full Text] [Related]

  • 32. Effects of a TAFI-inhibitor combined with a suboptimal dose of rtPA in a murine thromboembolic model of stroke.
    Durand A, Chauveau F, Cho TH, Kallus C, Wagner M, Boutitie F, Maucort-Boulch D, Berthezène Y, Wiart M, Nighoghossian N.
    Cerebrovasc Dis; 2014 Jul 19; 38(4):268-75. PubMed ID: 25401979
    [Abstract] [Full Text] [Related]

  • 33. Endovascular Treatment versus Sonothrombolysis for Acute Ischemic Stroke.
    Reinhard M, Taschner CA, Hörsch N, Allignol A, Maurer CJ, Niesen WD, Lambeck J, Wallesch CW, Urbach H, Weiller C, Schuchardt V, Griesser-Leute HJ.
    Cerebrovasc Dis; 2015 Jul 19; 40(5-6):205-14. PubMed ID: 26402300
    [Abstract] [Full Text] [Related]

  • 34. Usefulness of postischemic thrombolysis with or without neuroprotection in a focal embolic model of cerebral ischemia.
    Yang Y, Li Q, Miyashita H, Howlett W, Siddiqui M, Shuaib A.
    J Neurosurg; 2000 May 19; 92(5):841-7. PubMed ID: 10794299
    [Abstract] [Full Text] [Related]

  • 35. Comparative neuroprotective efficacy of prolonged moderate intraischemic and postischemic hypothermia in focal cerebral ischemia.
    Huh PW, Belayev L, Zhao W, Koch S, Busto R, Ginsberg MD.
    J Neurosurg; 2000 Jan 19; 92(1):91-9. PubMed ID: 10616087
    [Abstract] [Full Text] [Related]

  • 36. The role of connexin43 in hemorrhagic transformation after thrombolysis in vivo and in vitro.
    Yang X, Chu H, Tang Y, Dong Q.
    Neuroscience; 2016 Aug 04; 329():54-65. PubMed ID: 27138645
    [Abstract] [Full Text] [Related]

  • 37. Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke.
    Morris DC, Zhang L, Zhang ZG, Lu M, Berens KL, Brown PM, Chopp M.
    Stroke; 2001 Nov 04; 32(11):2635-40. PubMed ID: 11692028
    [Abstract] [Full Text] [Related]

  • 38. Effective and safe conditions of low-frequency transcranial ultrasonic thrombolysis for acute ischemic stroke: neurologic and histologic evaluation in a rat middle cerebral artery stroke model.
    Saguchi T, Onoue H, Urashima M, Ishibashi T, Abe T, Furuhata H.
    Stroke; 2008 Mar 04; 39(3):1007-11. PubMed ID: 18239172
    [Abstract] [Full Text] [Related]

  • 39. Conditions of protection by hypothermia and effects on apoptotic pathways in a rat model of permanent middle cerebral artery occlusion.
    Zhao H, Wang JQ, Shimohata T, Sun G, Yenari MA, Sapolsky RM, Steinberg GK.
    J Neurosurg; 2007 Sep 04; 107(3):636-41. PubMed ID: 17886565
    [Abstract] [Full Text] [Related]

  • 40. Combination therapy of moderate hypothermia and thrombolysis in experimental thromboembolic stroke--an MRI study.
    Kollmar R, Henninger N, Bardutzky J, Schellinger PD, Schäbitz WR, Schwab S.
    Exp Neurol; 2004 Nov 04; 190(1):204-12. PubMed ID: 15473993
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.